Rituximab-induced life-threatening coagulopathy occurring in a patient with Waldenstrom macroglobulinemia treated with fludarabine, cyclophosphamide, and rituximab combination

被引：3
|
作者：
Pilorge, Sylvain
Park, Sophie
Dreyfus, Francois
Bouscary, Didier
Tamburini, Jerome [1 ]
机构：
[1] Hop Cochin, AP HP, Serv Hematol, F-75014 Paris, France
来源：
LEUKEMIA & LYMPHOMA | 2010年 / 51卷 / 12期
关键词：
ACUTE THROMBOCYTOPENIA; LEUKEMIA;
D O I：
10.3109/10428194.2010.523127
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2288 / 2290
页数：3
相关论文
共 50 条
  • [1] Rituximab and Fludarabine or Cyclophosphamide Combination Treatment for Older Waldenstrom Macroglobulinemia Patients
    Xu, XiaoWei
    Wang, Chun
    Wang, YaMin
    Zhou, LiLi
    Bai, HaiTao
    TURKISH JOURNAL OF HEMATOLOGY, 2013, 30 (04) : 422 - 423
  • [2] Fludarabine, Cyclophosphamide and Rituximab (FCR) induced pulmonary hypertension in Waldenstrom macroglobulinemia
    Vladimir, Lazarevic L. J.
    Maria, Liljeholm
    Karin, Forsberg
    Stefan, Soederberg
    Anders, Wahlin
    LEUKEMIA & LYMPHOMA, 2008, 49 (06) : 1209 - 1211
  • [3] Fludarabine, Cyclophosphamide, and Rituximab in Salvage Therapy of Waldenstrom's Macroglobulinemia
    Tedeschi, Alessandra
    Ricci, Francesca
    Goldaniga, Maria Cecilia
    Benevolo, Giulia
    Varettoni, Marzia
    Motta, Marina
    Pioltelli, Pietro
    Gini, Guido
    Barate', Claudia
    Luraschi, Annamaria
    Vismara, Eleonora
    Frustaci, Anna Maria
    Nichelatti, Michele
    Vitolo, Umberto
    Baldini, Luca
    Morra, Enrica
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (02): : 231 - 234
  • [4] Life-threatening rituximab-induced pyoderma gangrenosum successfully treated with intravenous immunoglobulin
    Vikse, J.
    Rygh, A.
    Kaisen, K.
    Omdal, R.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (05) : 413 - 414
  • [5] Combination therapy with rituximab and fludarabine in Waldenstrom's Macroglobulinemia.
    Treon, SP
    Branagan, A
    Wasi, P
    Emmanouilides, CA
    Frankel, SR
    Lister, A
    Morel, P
    Matous, J
    Enschede, SH
    Kimby, E
    BLOOD, 2004, 104 (11) : 215A - 215A
  • [6] Fludarabine Plus Cyclophosphamide and Rituximab In Waldenstrom's Macroglobulinemia: Results In 55 Patients
    Leblond, Veronique
    Compain, Laetitia
    Levy, Vincent
    Tamburini, Jerome
    Delmer, Alain
    Vargaftig, Jacques
    Pegourie-Bandelier, Brigitte
    Mahe, Beatrice
    Le Guill, Steven
    Tournilhac, Olivier
    Brottier-Mancini, Elisabeth
    Delarue, Richard
    Buzyn, Agnes
    Maigre, Michel
    Gardin, Claude
    Choquet, Sylvain
    BLOOD, 2010, 116 (21) : 733 - 733
  • [7] Efficacy and long-term toxicity of the rituximab-fludarabine-cyclophosphamide combination therapy in Waldenstrom's macroglobulinemia
    Souchet, Laetitia
    Levy, Vincent
    Ouzegdouh, Maya
    Tamburini, Jerome
    Delmer, Alain
    Dupuis, Jehan
    Le Gouill, Steven
    Pegourie-Bandelier, Brigitte
    Tournilhac, Olivier
    Boubaya, Marouanne
    Vargaftig, Jacques
    Choquet, Sylvain
    Leblond, Veronique
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (08) : 782 - 786
  • [8] Combination therapy with rituximab and fludarabine is highly active in Waldenstrom's macroglobulinemia.
    Treon, SP
    Wasi, P
    Emmanouilides, CA
    Frankel, SR
    Kimby, E
    Lister, A
    Morel, P
    Kelliher, A
    Branagan, A
    Preffer, F
    Anderson, KC
    BLOOD, 2002, 100 (11) : 211A - 211A
  • [9] Life-threatening leflunomide pneumonitis in a patient on rituximab
    Jadon, Deepak R.
    Chan, Antoni
    McNally, Jeremy
    RHEUMATOLOGY, 2008, 47 : II158 - II159
  • [10] Fludarabine plus cyclophosphamide and rituximab (RFC) in Waldenstrom's macroglobulinemia (WM): Results in 25 patients
    Vargaftig, J.
    Pegourie-Bandelier, B.
    Mahe, B.
    Le Gouill, S.
    Brottier-Mancini, E.
    Delarue, R.
    Buzyn, A.
    Maigre, M.
    Gardin, C.
    Choquet, S.
    Leblond, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 227 - 227
12345